
==== Front
Womens Health (Lond)
Womens Health (Lond)
WHE
spwhe
Women's Health
1745-5057
1745-5065
SAGE Publications Sage UK: London, England

39287599
10.1177/17455057241277520
10.1177_17455057241277520
Meta-Analysis
Pregnancy outcomes in renal transplant recipients: A systematic review and meta-analysis
https://orcid.org/0000-0002-3067-3543
Mustafa Muhammad Saqlain 1Conceptualization Data curation Formal analysis Software Writing – review & editing
https://orcid.org/0000-0001-6970-9227
Noorani Amber 2Conceptualization Project administration Writing – original draft Writing – review & editing
https://orcid.org/0000-0002-8645-9669
Abdul Rasool Aniqa 3Conceptualization Data curation Validation Writing – original draft
https://orcid.org/0000-0002-7537-9719
Tashrifwala Fatema Ali Asgar 4Project administration Writing – original draft Writing – review & editing
Jayaram Shubha 5Methodology Writing – original draft
Raja Sandesh 6Data curation Writing – original draft
Jawed Fatima 6Data curation Writing – original draft
Siddiq Muhammad Usama 1Data curation Writing – original draft
Shivappa Sowmya Govindanahalli 7Methodology Writing – original draft
Hameed Ishaque 6Conceptualization Supervision Writing – review & editing
Dadana Sriharsha 8Supervision Writing – review & editing
1 Department of Medicine, Jinnah Sindh Medical University, Karachi, Pakistan
2 Department of Biochemistry, Jinnah Sindh Medical University, Karachi, Pakistan
3 Department of Pediatrics and Child Health, Aga Khan University Hospital, Karachi, Pakistan
4 Stamford Hospital, Stamford, CT, USA
5 Department of Biochemistry, Mysore Medical College and Research Institute, Mysore, Karnataka, India
6 Department of Medicine, Dow University of Health Sciences, Karachi, Pakistan
7 Department of Microbiology, JSS Medical College, JSS Academy of Higher Education and Research, Mysore, Karnataka, India
8 Department of Hospital Medicine, Cheyenne Regional Medical Center, Cheyenne, WY, USA
Amber Noorani, Department of Biochemistry, Jinnah Sindh Medical University, Rafiqui H.J. Road, Karachi 75050, Pakistan. Email: dr.ambernoorani@gmail.com
17 9 2024
2024
20 1745505724127752010 3 2024
21 7 2024
7 8 2024
© The Author(s) 2024
2024
SAGE Publications Ltd unless otherwise noted. Manuscript content on this site is licensed under Creative Commons Licenses
https://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
Background:

Kidney transplantation is a superior treatment for end-stage renal disease (ESRD), compared with hemodialysis, offering better quality of life and birth outcomes in women with ESRD and lower fertility rates.

Objectives:

To investigate the pregnancy, maternal, fetal, and graft outcomes following kidney transplantation in women with ESRD and evaluate the improvements in quality of life and associated risks.

Design:

A systematic review and meta-analysis performed according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses and the Meta-analysis of Observational Studies in Epidemiology guidelines.

Data Sources and Methods:

A thorough search of multiple databases, including PubMed, Embase, Scopus, ATC abstracts, and Cochrane Central Register of Controlled Trials, was conducted to identify studies that analyzed pregnancy outcomes in kidney transplant patients. The search was conducted from the inception of each database to January 2023.

Results:

The study reviewed 109 studies that evaluated 7708 pregnancies in 5107 women who had undergone renal transplantation. Of these, 78.48% resulted in live births, 9.68% had induced abortion, and 68.67% had a cesarean section. Miscarriage occurred in 12.54%, preeclampsia in 20.87%, pregnancy-induced hypertension in 24.30%, gestational diabetes in 5.08%, and preterm delivery in 45.30% of cases. Of the 853 recipients, 123 had graft loss after pregnancy and 8.06% suffered acute rejection.

Conclusion:

Pregnancy after kidney transplantation is associated with risks for mother and fetus; however, live births are still possible. In addition, there are reduced overall risks of stillbirths, miscarriages, neonatal deaths, and gestational diabetes.

Registration:

PROSPERO (CRD42024541659).

pregnancy
renal transplant
live births
neonatal mortality
graft outcomes
preeclampsia
cover-dateJanuary-December 2024
typesetterts1
==== Body
pmcIntroduction

Kidney transplantation, compared with hemodialysis, has significantly improved the quality of life of patients with end-stage renal disease (ESRD). 1 However, women of childbearing age (18–49 years) with ESRD have significantly lower fertility rates than do healthy women; besides, they have an increased risk of adverse pregnancy outcomes, such as preeclampsia, intrauterine growth restriction, preterm birth, and a decline in renal function.2,3 Therefore, renal transplantation is crucial for improving the prognosis and maternal and fetal outcomes in pregnant women with ESRD; in addition, it increases the rate of fertility in non-pregnant women owing to the rapid restoration of hormonal function. 2 Successful pregnancies have been reported in kidney transplant recipients since 1958, offering hope to those who wish to conceive. 4

Pregnancies in kidney transplant recipients are considered to have a better prognosis, compared with pregnancies in dialysis patients 1 ; however, such pregnancies pose challenges, including adverse maternal and fetal outcomes, such as preeclampsia, gestational diabetes, fetal growth restriction, preterm birth, and a high incidence of cesarean section. Exposure to immunosuppressants increases the chances of congenital disabilities in the unborn child, necessitating rigorous antenatal care and monitoring.5,6 Kidney transplantation is a common treatment option for women of childbearing age with ESRD; however, the limited availability of high-quality data has made it challenging to guide clinical decision making and support pregnant patients with kidney transplants. The increasing occurrence of such pregnancies in recent decades poses escalating challenges for nephrologists and obstetricians. Moreover, there is a paucity of literature, specifically panoptic meta-analyses, addressing the effects of renal transplantation on pregnancy, thus underscoring the need for further investigation. To address this gap, we aimed to conduct a systematic review and meta-analysis to provide a comprehensive overview of post-kidney transplantation pregnancy outcomes.

Methods

Data sources and search strategy

We conducted a systematic review and meta-analysis following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) and Meta-analysis of Observational Studies in Epidemiology guidelines7,8 to assess pregnancy outcomes in women older than >18 years who underwent kidney transplantation. This review was registered in the International Prospective Register of Systematic Reviews (PROSPERO; registration number CRD42024541659). We conducted a comprehensive search of several databases, such as PubMed, Embase, Scopus, ATC abstracts, and the Cochrane Central Register of Controlled Trials, spanning from inception of the database till January 2023. Our search strategy incorporated relevant Medical Subject Headings terms and pertinent keywords associated with pregnancy outcomes and kidney transplantation. The PubMed search string is provided in Supplemental File 1.

Study selection

All articles identified through the systematic search were exported to EndNote reference library version 20 (Clarivate Analytics, (US), LLC), where duplicates were removed. We included observational studies (prospective cohort, cross-sectional, and retrospective cohort studies), case series, and case reports (with >10 pregnancies) that assessed pregnancy, maternal, and fetal outcomes in women of reproductive age (>18 years of age) who had undergone kidney transplantation. Studies on patients with multiple organ transplants, studies that examined the teratogenic effects of sirolimus or mycophenolate, and non-English publications were excluded. Two investigators (MSM and FJ) independently reviewed the titles and abstracts of the identified studies. If eligibility could not be determined from the abstract, a full-text review was conducted. Any discrepancies were resolved by a third independent investigator (AAR).

Data extraction and quality assessment

Data extraction and quality assessment were performed by three authors (MUS, SR, and AAR) according to established protocols. All three authors verified the accuracy of the data, and any discrepancies were addressed through consultation with a fourth team member (MSM). The location, length, and duration of the study, the number of recipients of kidney transplants, number of pregnancies, mean maternal age, and mean time between kidney transplant and pregnancy were included in the extracted data. In addition, the number of live births, miscarriages, induced abortions, stillbirths, and ectopic pregnancies were included in the pregnancy outcomes. The following data were also included: the number of women with preeclampsia, gestational diabetes mellitus, and cesarean sections; the number of preterm births, mean gestational age, mean gestational weight, and number of neonatal deaths; and the number of graft failures and acute rejection episodes during and after pregnancy. The number of pregnancies was used as the denominator for outcomes, such as live births, miscarriages, induced abortions, stillbirths, ectopic pregnancy, preeclampsia, pregnancy-induced hypertension (PIH), and gestational diabetes mellitus, to guarantee uniformity of the collected data. However, the denominator for preterm delivery, cesarean section, and neonatal mortality was the count of live births. For acute rejection, the denominator was the total number of recipients. A live delivery before 37 weeks of gestation was considered preterm.

Statistical analysis/meta-analysis

The study presented patients’ demographic parameters as frequencies and expressed pregnancy incidence as the proportion of women per 1000 live births. Prevalence with 95% confidence intervals (CIs) was used to demonstrate each included study’s estimates, and a random-effects model was used to pool the data from individual studies. The Higgins I 2 statistic value was used for heterogeneity evaluation, and a value of >50% was considered significant. For binary outcomes, the Der Simonian and Laird approach was applied; for continuous outcomes, the weighted average methodology was used to compute the pooled estimates and 95% CIs. Furthermore, the study investigated the association between maternal age, the gap between kidney transplants and pregnancy, and pregnancy success. It also offered incidents per 100 observations for continuous outcomes. A location-based subgroup analysis of the pregnancy, maternal, and fetal outcomes was performed. R meta package was used for the analyses. In addition, we conducted a sensitivity analysis using leave-one-out analysis to identify the trials causing significant heterogeneity.

Results

Of the 4425 articles that were retrieved, 2088 full-text articles were reviewed, and 109 were eventually selected for inclusion in the final study,9 –116 as shown in the PRISMA flow diagram (Figure 1). The total number of pregnancies was 7728 in 5107 transplant recipients. The mean maternal age was 30.3 ± 3.21 years, and the mean interval from transplant to pregnancy was 5.6 ± 1.95 years. Baseline characteristics of the included studies are presented in Table 1. Maternal demographics and pregnancy, maternal, and fetal outcomes are presented in Table 2. Forty-one studies conducted in Asia, 5 in Africa, 39 in Europe, 9 in South America, 10 in North America, and 5 in Oceania were included (Table 3).

Figure 1. PRISMA flow chart summarizing the systematic review process according to PRISMA guidelines, showing the number of records identified, screened, assessed for eligibility, and included in the systematic review and meta-analysis.

PRISMA: Preferred Reporting Items for Systematic Reviews and Meta-Analyses.

Table 1. Baseline characteristics of included studies.

Author/study name	Year	Country	Years of data collection	Total number of kidney transplant recipients	Total number of pregnancies	
Gosselink et al. (2022) 9	2022	Netherland	1971–2017	192	288	
Devresse et al. (2022) 10	2022	Belgium	1994–2010	32	57	
Schwarz et al. (2022) 11	2022	Germany	1972–2009	67	92	
Dines et al. (2021) 12	2021	USA	1996–2014	25	52	
Puthenveettil et al. (2021) 13	2021	India	2011–2017	20	20	
Mira et al. (2021) 14	2021	Portugal	1989–2019	34	41	
Turgut et al. (2021) 15	2021	Turkey	2010–2019	20	20	
Akcay et al. (2021) 16	2021	Turkey	2001–2017	18	29	
Kovač et al. (2021) 17	2020	Slovenia	1970–2016	18	22	
Dębska-Ślizień et al. (2020) 18	2020	Poland	1987–2018	26	31	
Madazlı et al. (2020) 19	2020	Turkey	2010–2018	32	32	
Ying et al. (2020) 20	2020	China	2000–2017	11	11	
Golocan-Alquiza et al. (2019) 21	2019	Philippines	2001–2016	32	38	
Hortu et al. (2019) 22	2019	Turkey	1995–2017	51	52	
Mariano et al. (2019) 23	2019	Brazil	1995–2017	22	19	
Ozban et al. (2019) 24	2019	Turkey	2006–2018	5	6	
Tebet et al. (2019) 25	2019	Brazil	2014–2016	43	43	
Mohamed Hassan et al. (2018) 26	2018	Egypt	N/A	44	44	
Amine et al. (2017) 27	2017	Tunisia	1992–2011	12	17	
Mohammadi et al. (2017) 28	2017	Australia	1976–2015	35	56	
Itabashi et al. (2017) 29	2017	Japan	1983–2015	26	34	
Kihara et al. (2018) 30	2018	Japan	1985–2016	7	7	
Songin et al. (2014) 31	2014	Poland	1999–2011	37	43	
Piccoli et al. (2017) 1	2017	Italy	2000–2014	121	121	
Yuksel et al. (2017) 32	2017	Turkey	2009–2016	25	25	
Ajaimy et al. (2016) 33	2016	USA	2009–2014	11	11	
Candido et al. (2016) 34	2016	Portugal	2004–2014	36	53	
Cristelli et al. (2016) 35	2016	Brazil	2004–2014	36	53	
El Houssni et al. (2016) 36	2016	Saudi Arabia	1998–2012	12	21	
Lima et al. (2016) 37	2016	Brazil	2004–2014	36	53	
Majak et al. (2016) 38	2016	Norway	1969–2013	119	119	
Mishra et al. (2016) 39	2016	India	2004–2014	16	16	
Orihuela et al. (2016) 40	2016	Uruguay	1986–2014	32	40	
Piccoli et al. (2016) 41	2016	Italy	1978–2013	N/A	189	
Saliem et al. (2016) 42	2016	Canada	2006–2011	N/A	264	
Santos et al. (2016) 43	2016	Portugal	2010–2014	8	8	
Sarween et al. (2016) 44	2016	UK	2001–2015	387	569	
Stoumpos et al. (2016) 45	2016	UK	1973–2013	89	138	
Yoshikawa et al. (2016) 46	2016	Japan	N/A	49	65	
Aktrurk et al. (2015) 47	2015	Turkey	2004–2014	12	16	
Arab et al. (2015) 48	2015	Canada	2003–2010	N/A	275	
Erman et al. (2015) 49	2015	Turkey	1987–2011	43	43	
Yeon et al. (2015) 50	2015	Korea	1995–2015	84	119	
Debska-Slizien et al. (2014) 51	2014	Poland	1980–2012	17	22	
Farr et al. (2014) 52	2014	Austria	1999–2013	12	12	
Hebral et al. (2014) 53	2014	France	1969–2011	46	61	
You et al. (2014) 54	2014	Korea	1995–2013	29	41	
Blume et al. (2013) 55	2013	Germany	1988–2010	34	53	
Guella et al. (2013) 56	2013	Saudi Arabia	1992–2008	15	33	
Rachdi et al. (2013) 57	2013	Tunisia	2003–2013	12	17	
Ribeiro et al. (2013) 58	2013	Brazil	1995–2007	22	31	
Rocha et al. (2013) 59	2013	Portugal	1983–2009	24	24	
Wyld et al. (2013) 60	2013	Australia	1971–2010	447	692	
Kennedy et al. (2012) 61	2012	Ireland	—	18	29	
Neyatani et al. (2012) 62	2012	Japan	1975–2011	22	34	
Van Buren et al. (2012) 63	2012	Netherlands	1971–2010	30	42	
Celik et al. (2011) 64	2011	Turkey	1998–2008	24	31	
Gerlei et al. (2011) 65	2011	Hungary	1974–2010	23	25	
Lopez et al. (2011) 66	2011	Spain	1986–2010	20	24	
Xu et al. (2011) 67	2011	China	1989–2008	25	38	
Gorgulu et al. (2010) 68	2010	Turkey	1983–2008	19	22	
Areia et al. (2009) 69	2009	Portugal	1989–2007	28	34	
Gill et al. (2009) 70	2009	USA	1990–2003	483	530	
Levidiotis et al. (2009) 71	2009	Australia	1966–2005	381	577	
Rizvi et al. (2009) 72	2009	Pakistan	1985–2008	N/A	72	
Sharma et al. (2009) 73	2009	Oman	1988–2006	42	82	
Al Duraihimh et al. (2008) 74	2008	Middle East	1996–2006	140	234	
Alfi et al. (2008) 75	2008	Saudi Arabia	1989–2005	12	20	
Cruz Lemini et al. (2007) 76	2007	Mexico	1990–2005	60	75	
Oliveira et al. (2007) 77	2007	Brazil	2001–2005	52	52	
Sibanda et al. (2007) 78	2007	UK	1994–2001	176	193	
Yassaee et al. (2007) 79	2007	Iran	1996–2001	74	95	
Kurata et al. (2006) 80	2006	Japan	1984–2003	42	53	
Rahamimov et al. (2006) 81	2006	Israel	1983–1998	39	69	
Galdo et al. (2005) 82	2005	Chile	1982–2002	30	37	
Garcia-Donaire et al. (2005) 83	2005	Spain	1997–2004	16	19	
Ghanem et al. (2005) 84	2005	Egypt	1989–2004	41	67	
Pour-Reza-Gholi et al. (2005) 85	2005	Iran	1984–2004	60	74	
Yildirim et al. (2005) 85	2005	Turkey	1998–2005	17	20	
Keitel et al. (2004) 87	2004	Brazil	1977–2001	41	44	
Pezeshki et al. (2004) 88	2004	Iran	1991–1998	18	20	
Hooi et al. (2003) 89	2003	Malaysia	1984–2001	46	72	
Queipo et al. (2003) 90	2003	Spain	1980–2000	29	40	
Thompson et al. (2003) 91	2003	UK	1976–2001	24	48	
Sgro et al. (2002) 92	2002	Canada	1988–1998	26	44	
Tan et al. (2002) 93	2002	Singapore	1986–2000	25	42	
Park et al. (2001) 94	2001	South Korea	N/A–2000	36	47	
Kuvacic et al. (2000) 95	2000	Croatia	1986–1996	15	23	
Little et al. (2000) 96	2000	Ireland	1985–1998	19	29	
Moon et al. (2000) 97	2000	Korea	N/A–1998	36	48	
Ventura et al. (2000) 98	2000	Portugal	1983–1999	15	15	
Arsan et al. (1997) 99	1997	France	N/A	20	33	
Rahbar et al. (1997) 100	1997	Iran	1985–1993	13	14	
Rieu et al. (1997) 101	1997	France	1970–1995	22	33	
Al Hassani et al. (1995) 102	1995	Oman	1985–1993	25	44	
Sabagh et al. (1995) 103	1995	Saudi Arabia	1984–1994	33	52	
Saber et al. (1995) 104	1995	Brazil	1968–1992	19	25	
Wong et al. (1995) 105	1995	New Zealand	1972–1992	9	16	
Hadi et al. (1986) 106	1986	South Korea	1969–1992	11	17	
Talaat et al. (1994) 107	1994	Sweden	1977–1992	19	25	
Pahl et al. (1993) 108	1993	USA	1969–1990	21	32	
Muirhead et al. (1992) 109	1992	UK	1977–1988	22	22	
Brown et al. (1991) 110	1991	Ireland	1965–1989	14	27	
Sturgiss et al. (1991) 111	1991	UK	1967–1987	17	22	
O’Connell et al. (1989) 112	1989	Australia	1974–1986	11	18	
Ha et al. (1994) 113	1994	Korea	1970–1982	11	13	
Marushak et al. (1986) 114	1986	Denmark	1972–1983	20	24	
O’Donnell et al. (1985) 115	1985	South Africa	1971–1984	21	38	
Waltzer et al. (1980) 116	1980	USA	N/A	12	15	
N/A: not applicable.

Table 2. Maternal demographics, pregnancy outcomes, obstetric complications and delivery outcomes among kidney transplant recipients.

Demographic/Outcome	Statistics/Results	95% confidence interval	
Number of papers	109		
Number of pregnancies	7728		
Number of recipients	5107		
Mean maternal age (years) a	30.31 ± 3.21		
Mean interval from transplant to pregnancy	5.6 ± 1.95 years		
Pregnancy outcomes			
 Live birth	78.48%	75.48–81.49	
 Induced abortion	9.68%	7.67–11.69	
 Miscarriages	12.54%	10.61–14.47	
 Still birth	3.06%	2.35–3.77	
 Cesarean section	68.67%	63.95–73.39	
 Ectopic pregnancies	0.94%	0.12–1.77	
Maternal outcomes			
 Preeclampsia	20.87%	18.25–23.48	
 Pregnancy-induced hypertension	24.30%	18.40–30.20	
 Gestational diabetes	5.08%	3.61–6.55	
Fetal outcomes			
 Preterm delivery	45.30%	41.26–49.34	
 Neonatal mortality	1.50%	0.87–2.13	
 Mean gestation time (weeks) a	34.35 ± 2.36		
 Mean birth weight (g) a	2387.79 ± 241.67		
Graft outcomes			
 Acute rejection	8.06%	5.61–10.51	
 Mean creatinine before pregnancy (mg/dL)	1.16 ± 0.16		
 Mean creatinine after pregnancy(mg/dL)	1.36 ± 0.18		
 Graft loss post-pregnancy (out of 19 Studies, 853 recipients)	123 cases (14.42%)		
a Reported in mean ± standard deviation. Remaining outcomes reported in rates in percentage.

Table 3. Number of studies according to region.

Asia	41 studies	
Africa	5 studies	
Europe	39 studies	
South America	9 studies	
North America	10 studies	
Oceania	5 Studies	

Pregnancy outcomes

The total number of events reported was 5974, of which live births comprised 78.48% (n = 4505; 95% CI, 75.48–81.49), which was higher than the percentage in the United States (US) general population (56.6%) 117 and was favorable across all geographic locations. The percentage of induced abortions was 9.68% (n = 567; 95% CI, 7.67–11.69) and that of miscarriages was 12.54% (n = 688; 95% CI, 10.61–14.47), both of which were lower than those in the US general population (24.8% and 19.8%, respectively). 118 The rate of stillbirths was 3.06% (n = 189; 95% CI, 2.35–3.77), which was lower than that in the US general population (5.74%). 119 Ectopic pregnancies were reported in 0.94% (n = 25; 95% CI, 0.12–1.77) of transplant recipients, which was lower than that in the US general population (1.4%). 120 The rate of ectopic pregnancy in the present study differed from the result of a previous meta-analysis, which found an ectopic pregnancy rate higher than that in the US general population (2.4% vs 1.4%). 120 Globally, the live birth rate was highest in Europe (84.50%); however, it was generally favorable across all geographic regions: Africa (80.69%), Asia (74.41%), North America (70.57%), South America (76.90%), and Oceania (76.35%) (Figure 2). The induced abortion rate was highest in South America (17.02%), followed by Asia (11.91%), Oceania (10.28%), North America (8.07%), Europe (7.03%), and Africa (6.39%) (Figure 3). The overall miscarriage rate was low, with the lowest incidence in Oceania (8.64%), followed by Asia (12.02%), Europe (12.24%), Africa (12.71%), North America (14.59%), and South America (17.07%) (Figure 4). The overall stillbirth rate was linear worldwide, with the highest rate in Asia (3.7%) and the lowest in North America (1.48%) (Figure 5). The overall incidence of ectopic pregnancy was low, with the highest rate in North America (2.64%) (Figure 6).

Figure 2. Forest plot illustrating the incidence of live births among kidney transplant recipients, both globally and within distinct geographical regions.

Figure 3. Forest plot illustrating the occurrence of induced abortions among kidney transplant recipients overall and in various geographical regions.

Figure 4. Forest plot illustrating the incidence of miscarriages among kidney transplant recipients overall and in diverse geographical regions.

Figure 5. Forest plot depicting the occurrence of stillbirths among kidney transplant recipients overall and across various geographical regions.

Figure 6. Forest plot illustrating the outcomes of ectopic pregnancies among kidney transplant recipients both overall and across different geographical regions.

Maternal outcomes

The maternal outcomes included in our study were preeclampsia, cesarean section, gestational diabetes, and PIH. Of these, the most frequently reported outcome was a cesarean section, at 68.67% (n = 2043; 95% CI, 63.95–73.39), which was twice as high as that in the US general population (32.1%). 121 This was followed, in descending order, by PIH (24.30%) (n = 491; 95% CI, 18.40–30.20), preeclampsia (20.87%) (n = 864; 95% CI, 18.25–23.48), and gestational diabetes (5.08%) (n = 224; 95% CI, 3.61–6.55). Although the rate of preeclampsia in the US population was six times lower than that in our study (3.8%), 122 the rate of gestational diabetes in the US population was higher than that in our study (7.8% vs. 5.08%). 123 Globally, the overall cesarean section rate was high, with the highest rate reported in South America (89.4%), followed by Africa (70.6%); the lowest rate was reported in North America (61.4%) (Figure 7). There was an overall increase in the rate of preeclampsia, with the highest rate reported in Oceania (27.3%), followed by North America (25.6%), Asia (22.0%), Europe (19.17%), South America (18.27%), and Africa (16.21%) (Figure 8). Gestational diabetes rates were significantly promising worldwide, with the lowest incidence reported in Oceania (0.65%) and the highest in Europe (7.09%) (Figure 9). Lastly, the rate of PIH was highest in South America (51.3%) and lowest in Africa (15.5%) (Figure 10).

Figure 7. Forest plot displaying the outcomes of cesarean sections among kidney transplant recipients overall, as well as across different geographical regions.

Figure 8. Forest plot depicting the occurrence of preeclampsia among kidney transplant recipients overall and in various geographical regions.

Figure 9. Forest plot illustrating the incidence of gestational diabetes among kidney transplant recipients overall and across diverse geographical regions.

Figure 10. Forest plot demonstrating the occurrence of pregnancy-induced hypertension among kidney transplant recipients overall and in various geographical regions.

Fetal outcomes

The fetal outcomes considered in our study included preterm delivery, neonatal mortality, mean gestational age, and mean birth weight. Preterm birth is defined as babies born alive before 37 weeks of gestation. 124 Neonatal mortality is defined as the number of deaths during the first 28 days of life per 1000 live births each year or in another period. 125 The overall rate of preterm birth was 45.3% (n = 1620; 95% CI, 41.26–49.34), compared with 10.8% in the US general population 117 ; neonatal mortality was 1.89% (n = 60; 95% CI, 1.07–2.71), compared with 3.4% in the US general population. 126 The rate of preterm births was highest in South America (59.8%) and lowest in Asia (39.3%) (Figure 11). Neonatal mortality was highest in Africa (31%), followed by Asia (2.69%), showing a significantly lower rate; no neonatal mortalities were reported in North America (0.00%) (Figure 12). The average birth weight of the infants was 2387.7 g (US mean birth weight, 3389 g), and their mean gestational age was 34.3 weeks (US mean gestational age, 38.7 weeks)127,128 (Table 2).

Figure 11. Forest plot illustrating the occurrence of preterm births among kidney transplant recipients overall and across various geographical regions.

Figure 12. Forest plot illustrating the occurrence of neonatal mortality among kidney transplant recipients overall and across diverse geographical regions.

Graft outcomes

Regarding 911 kidney transplant recipients, the total acute rejection rate during pregnancy was 8.06% (n = 92; 95% CI, 5.61–10.51). This rate is comparable to the average rejection rate in transplant recipients in the US general population (7.1%). 129 The following are the rates in each region: Asia, 12.14%; South America, 9.6%; Oceania, 9.09%; North America, 6.67%; Europe, 5.54%; and Africa, 4.76%. Asia had the highest acute renal allograft rejection rates (Figure 13). Although there was a significant variation in graft failure during the follow-up period (1–14 years), there were 123 cases of graft loss (14.42%) among 853 recipients in 19 studies in which 2-year post-pregnancy graft loss was reported. Mean creatinine before pregnancy (mg/dL) and mean creatinine after pregnancy (mg/dL) were 1.16 ± 0.16 and 1.36 ± 0.18, respectively.

Figure 13. Forest plot displaying the rates of acute rejection among kidney transplant recipients overall and across various geographical regions.

Sensitivity analysis

Sensitivity analyses were performed using the leave-one-out method for some outcomes with high heterogeneity to evaluate the studies responsible for heterogeneity, enhance the accuracy of our research findings, and provide more reliable results. The live birth rate after sensitivity analysis was 74.6%, compared with the mean of 56.6% in the US. 117 The miscarriage rate was 13.6%, compared to 19.8% in the US general population. 118 The rate of induced abortions was 7.1%, compared with 24.8% in the US general population. 118 The rates of preeclampsia and gestational diabetes were 20.36% and 3.7%, respectively, compared with 3.8% 122 and 7.8%, 123 respectively, in the US general population. After sensitivity analysis, the rate of PIH was lower than that in the US general population (24.3% vs. 13.7%), whereas the cesarean section rate was higher (74.5%) than the rate in the US (32.1%). 122 Ultimately, the preterm birth rate was 45.3% in the sensitivity analysis. The preterm birth rate in the US general population was 10.8% (Supplemental Figures 1–8). 116

Interval between renal transplant and pregnancy

The study analyzed pregnancy-related outcomes, based on the interval between renal transplantation and the time of conception, which was categorized into three groups: <2, 2–3, and >3 years. The <2-year interval analysis was based on four studies comprising 141 pregnancies; the 2–3-year interval analysis was based on 11 studies that included 400 pregnancies; and the >3-year interval analysis was based on 66 studies, encompassing a total of 4748 pregnancies.

In cases where the interval between pregnancies was <2 years, the live birth rate was 81.96%, whereas the rates of induced abortion, spontaneous abortion, stillbirth, and neonatal death were 3.59%, 12.72%, 8.04%, and 2.44%, respectively. The maternal outcomes in these cases included a cesarean section rate of 54.6%, a preeclampsia rate of 18.6%, and a PIH rate of 15.9%. Fetal outcomes revealed a preterm delivery rate of 45.2%, a mean gestational age of 37.11 weeks, and an average birth weight of 2868.5 g. The acute rejection and graft loss rates were 11.95% and 16.67%, respectively.

In cases where the interval between pregnancies was 2–3 years, the live birth rate was 73.13%, whereas the rates of induced abortion, spontaneous abortion, stillbirth, and neonatal death were 14%, 12.61%, 3.31%, and 2.80%, respectively. Maternal outcomes in these cases included a cesarean section rate of 74.02%, preeclampsia rate of 25.95%, PIH rate of 28.79%, and gestational diabetes rate of 8.76%. Fetal outcomes revealed a preterm delivery rate of 47.70%, a mean gestational age of 33.7 weeks, and an average birth weight of 2463.74 g. Regarding graft outcomes, the acute rejection rate was 19.58%.

In cases where the interval between pregnancies was >3 years, the live birth rate was 81.89%, whereas the rates of induced abortion, spontaneous abortion, stillbirth, and neonatal death were 10.72%, 12.67%, 2.65%, and 1.65%, respectively. Maternal outcomes in these cases included a cesarean section rate of 70.76%, preeclampsia rate of 21.81%, PIH rate of 21.69%, and gestational diabetes rate of 5.25%. Fetal outcomes revealed a preterm delivery rate of 45.30%, a mean gestational age of 35.32 weeks, and an average birth weight of 2470.77 g. Regarding graft outcomes, the acute rejection rate was 4.21%, whereas the graft loss rate was 14.49% (Table 4; Supplemental Figures 9–20).

Table 4. Pregnancy-related outcomes stratified by study mean interval between transplant and pregnancy.

Mean interval between transplant and pregnancy	< 2 years	2–3 years	>3 years	
Number of papers	4	11	66	
Number of pregnancies	131	400	4748	
Mean maternal age (years)	28.45	28.04	29.15	
Pregnancies outcomes				
 Live birth	81.96%	73.13%	81.89%	
 Induced abortion	3.59%	14%	10.72%	
 Spontaneous abortion	12.72%	12.61%	12.67%	
 Still birth	8.04%	3.31%	2.65%	
 Neonatal deaths	2.44%	2.80%	1.65%	
Maternal outcomes				
 Cesarean section	54.63%	74.02%	70.76%	
 Preeclampsia	18.60%	25.95%	21.81%	
 Pregnancy-induced hypertension	15.97%	28.79%	21.69%	
 Gestational diabetes	N/A	8.76%	5.25%	
Fetal outcomes				
 Preterm delivery	45.25%	47.70%	44.86%	
 Mean gestational age (weeks)	37.11	33.7	35.32	
 Birth weight (g)	2868.5	2463.74	2470.77	
Graft outcomes				
 Acute rejection	11.95%	19.58%	4.21%	
 Graft loss	16.67%	N/A	14.49%	
N/A: not applicable.

Maternal age at conception

Pregnancy-related outcomes were stratified into four groups based on the mean maternal age: <25, 25–29, 30–34, and >35 years. The analysis for the <25-years age group was based on 10 studies with 299 pregnancies. For the 25–29-year age group, we analyzed 38 studies with 2588 pregnancies. The analysis of the 30–34-year age group was based on 36 studies with 2939 pregnancies. For the >35-years age group, we included only one study with 11 pregnancies.

The live birth rate was 75.04% among individuals aged <25 years. The rates of induced abortions, spontaneous abortions, and stillbirths were 14.89%, 14.88%, and 2.15%, respectively. Maternal outcomes included a cesarean section rate of 74.07%, preeclampsia rate of 12.29%, PIH rate of 20.95%, and gestational diabetes rate of 2.12%. Fetal outcomes revealed a preterm delivery rate of 56.87%, a mean gestational age of 33.7 weeks, and an average birth weight of 2483.4 g. Graft outcomes showed an acute rejection rate of 6.67% and a graft loss rate of 0.00%.

For individuals aged 25–29 years, the live birth rate was 79.23%. The rates of induced abortions, spontaneous abortions, stillbirths, and neonatal deaths were 12.67%, 14.73%, 3.34%, and 2.68%, respectively. Maternal outcomes included a cesarean section rate of 72.79%, preeclampsia rate of 23.57%, PIH rate of 23.80%, and gestational diabetes rate of 6.32%. Fetal outcomes revealed a preterm delivery rate of 47.57%, a mean gestational age of 35.36 weeks, and an average birth weight of 2481.50 g. Graft outcomes showed an acute rejection rate of 7.97% and a graft loss rate of 9.49%.

For individuals aged 30–34 years, the live birth rate was 80.79%. The rates of induced abortion, spontaneous abortion, stillbirth, and neonatal death were 8.93%, 12.93%, 2.84%, and 1.53%, respectively. Maternal outcomes included a cesarean section rate of 68.93%, preeclampsia rate of 22.68%, PIH rate of 24.62%, and gestational diabetes rate of 4.32%. Fetal outcomes revealed a mean preterm delivery rate of 42.18%, a mean gestational age of 35.25 weeks, and an average birth weight of 2462.9 g. The graft outcomes showed an acute rejection rate of 5.20% and a graft loss rate of 13.26%.

For individuals aged >35 years, the live birth rate was reported to be 100%. However, the rates of spontaneous abortion, stillbirth, and preeclampsia were reported to be 18.18%, 9.09%, and 27.27%, respectively. As for graft outcomes, the graft loss rate was 27.27% (Table 5; Supplemental Figures 21–32).

Table 5. Pregnancy-related outcomes stratified by study mean maternal age.

Mean maternal age (years)	<25	25–29	30–34	>35	
Number of papers	10	38	36	1	
Number of pregnancies	299	2588	2939	11	
Mean maternal age (years)	23.13	28.09	31.5	36	
Pregnancy outcomes					
 Live birth	75.04%	79.23%	80.79%	100%	
 Induced abortion	14.89%	12.67%	8.93%	N/A	
 Spontaneous abortion	14.88%	14.73%	12.93%	18.18%	
 Still birth	2.15%	3.34%	2.84%	9.09%	
 Neonatal deaths	0.00%	2.68%	1.53%	N/A	
Maternal outcomes					
 Cesarean section	74.07%	72.79%	68.93%	N/A	
 Preeclampsia	12.29%	23.57%	22.68%	27.27%	
 Pregnancy-induced hypertension	20.95%	23.80%	24.62%	N/A	
 Gestational diabetes	2.12%	6.32%	4.32%	N/A	
Fetal outcomes					
 Preterm delivery	56.87%	47.57%	42.18%	N/A	
 Mean gestation time (weeks)	33.7	35.36	35.25	N/A	
 Birth weight (g)	2483.4	2481.50	2462.9	N/A	
Graft outcomes					
 Acute rejection	6.67%	7.97%	5.20%	N/A	
 Graft loss	0.00%	9.49%	13.26%	27.27%	
N/A: not applicable.

Discussion

The findings of our meta-analysis suggest that, although most pregnancies in women who have undergone kidney transplantation resulted in live births, there were significant incidences of maternal and fetal adverse events. The most common adverse outcomes were cesarean section, preterm delivery, PIH, and pre-eclampsia. Other significant adverse outcomes included gestational diabetes, neonatal mortality, stillbirth, miscarriage, and induced abortion. Compared with the rates in the US general population, this study reported higher rates of live births, stillbirths, preeclampsia, and cesarean sections but lower rates of ectopic pregnancies, gestational diabetes, mean gestational age, birth weight, and graft rejection.

Our study reported a higher live birth rate compared with that in the US general population. 117 The 2018 Annual Report of the Transplant Pregnancy Registry International reported a 75% live birth rate in renal transplant recipients. 130 However, a single-center study reported a lower live birth rate, of only 33.3%, among 182 renal transplant recipients. 131 The high live birth rate in our study may be attributed to reporting and selection bias and the exclusion of pregnancies with confirmed intrauterine fetal abnormalities and/or transplant recipients managed with teratogenic immunosuppressants, such as mycophenolate and sirolimus. Our study’s live birth rate agrees with the live birth rates of 72.9% and 73.5% reported in previous meta-analyses by Shah et al. and Deshpande et al., respectively.120,132

Although our study reports encouraging live birth rates, preterm delivery-induced abortions and miscarriages are common. The preterm birth rate in our study was approximately three-fold higher than that in the US general population, 117 and similar rates (50%–64%) have been reported by the UK, US, and European transplant registries. 133 The higher preterm delivery rate may be due to greater risk factors in renal transplant recipients, such as premature rupture of membranes, urinary tract infections, and acute graft rejection. 134 However, the literature suggests that iatrogenic preterm deliveries should be reserved for patients with suspected fetal renal compromise and preeclampsia. 135

The higher rates of induced abortion and miscarriages in the US than those in our study may be due to the use of mycophenolate, which is associated with a higher risk of miscarriage and fetal malformation. 136 Thus, it is essential to advise transplant recipients to discontinue mycophenolate for at least 6 weeks before conception. 137 Consequently, the lower rates of abortions and miscarriages in our study may be due to the selection of women who were qualified to continue with their pregnancies. Neonatal mortality and stillbirth rates in our study were comparatively lower than the rates in the US119,126; however, excessive preventive measures in terms of pre-pregnancy counseling and antenatal care are still required. Similar neonatal mortality rates have been described in a retrospective cohort study with data pooled from the Australia and New Zealand Dialysis and Transplant Registry and perinatal datasets, advocating the need for antenatal care and preconception counseling for pregnancies in renal transplant recipients. 138

Our study highlights the significantly increased risk of complications for mothers who have undergone kidney transplantation, with preeclampsia affecting almost a quarter of women and being approximately six times more common than that in the US population. 122 Preeclampsia can lead to several maternal and fetal complications and poses a significant challenge for clinicians in terms of diagnosis and management. 132 Our research outcomes correspond with those reported by Coscia et al., who observed notably elevated incidence rates of preeclampsia (31%) and hypertension (54%) in female transplant recipients. 135 Furthermore, in another study of 15 female transplant recipients, the rate of hypertension was 46.6%. 139 The high rate of hypertension in pregnant transplant recipients could be associated with the use of calcineurin inhibitors and corticosteroids, donor kidney type, and modifiable maternal factors, such as smoking, alcohol consumption, and obesity. 140

The incidence of gestational diabetes in transplant recipients was lower in our study than in the US general population 123 ; however, close monitoring is important because of the potential risks for the mother and newborn. Moreover, factors such as immunosuppressive drugs, like tacrolimus, pre-existing conditions such as obesity, family history of diabetes, and advanced maternal age can increase this risk. 141 Women who have received a transplant require guidance on managing pre-existing conditions before becoming pregnant to optimize their health before conception. 142

Regarding the regional disparities in acute renal allograft rejection rates, observed variations, Asia had the highest rejection rates followed by South America, Oceania, North America, Europe, and Africa. Medical management, including pre-transplant evaluation and preparation, surgical techniques, post-operative care, immunosuppressive therapy protocols, and monitoring strategies, are more accessible in developed countries than in developing countries. Moreover, regions with higher rejection rates face challenges related to access to advanced medical technology, medications, or healthcare professionals specialized in transplant care. In contrast, regions with lower rejection rates, like Europe and North America, have extensive resources in transplant centers. Furthermore, variations in donor characteristics, such as donor age, Human Leukocyte Antigens matching, and organ preservation techniques affect transplant outcomes and rejection rates. Regions with limited access to suitable donors or where donor quality may be compromised could experience higher rejection rates, compared with regions with more favorable donor profiles. 143

The mode of delivery for renal transplant recipients remains controversial. In our study, the rate of cesarean sections in renal transplant recipients was at least twice as high as that in the US general population, 122 and several studies have reported similar findings.144,145 The reasons for this include non-medical factors, such as fear of infection and graft injury, newborn welfare, and low optimism for a trial of labor. However, trials of labor and normal delivery did not increase the risk of renal and cardiovascular complications, allograft injury, or sepsis, as suggested by Yin et al. 146 Therefore, cesarean delivery should only be reserved for obstetric reasons, and hospital and delivery unit policies should be revised to lower the rate of cesarean delivery after organ transplantation. Preconception and prenatal care within a patient’s transplant center may improve interdisciplinary management and communication during vaginal delivery. 146

The optimal time interval between transplantation and pregnancy remains debatable. Previously, it was suggested that pregnancy should be delayed for at least 2 years post-transplantation; however, these guidelines have been replaced by the American Society of Transplantation guidelines, which suggest that a transplant recipient can conceive as early as 1-year post-transplantation. 133 Our study showed fewer adverse outcomes and rates with intervals of <2 years, whereas more outcomes and higher rates were found with a 2–3-year interval between transplantation and pregnancy. These outcomes include induced abortion, neonatal death, cesarean delivery, preeclampsia, PIH, gestational diabetes, and acute graft rejection. The mean gestational age and live birth rates were lowest in the 2–3-year interval and highest in the <2 year interval. This is consistent with a meta-analysis by Shah et al. that reported the lowest rates of fetal and maternal complications within 2 years of transplantation, whereas the outcomes were reported to be the highest during the 2–3-year interval. 120 Another study reported that 97% of transplant recipients had successful pregnancies 1 year after transplantation, with 73% having live births. 71 This finding reinforces the importance of following the current guidelines regarding the optimal time interval between transplantation and pregnancy, as well as including preconception counseling, family planning, and contraception as crucial components of the transplant counseling process. 132

Our study provides valuable information on pregnancy outcomes in renal transplant recipients from a diverse region-specific population over several decades. This information can assist in updating the guidelines and management of pregnancy in transplant recipients that are specific to a particular region. However, this study has limitations, including potential bias in participant selection and data reporting owing to voluntary participation. This study excluded patients treated with mycophenolate and sirolimus, which may have affected the overall favorable results of the meta-analysis. Therefore, future research should further investigate this parameter. In addition, there were inconsistencies in the diagnostic criteria for complications such as PIH, preeclampsia, and gestational diabetes, as well as potential confounding factors, such as baseline variations in medical care and socioeconomic differences between countries and regions. The absence of comprehensive data on post-pregnancy reproductive planning among transplant recipients limits the depth of our analysis. This underscores the need to address this crucial aspect of care, considering the associated risks.

Conclusion

Pregnancy after kidney transplantation poses significant risks to maternal and fetal health, including preeclampsia, hypertension, cesarean delivery, stillbirth, preterm birth, and low birth weight. Our meta-analysis revealed variations in outcomes across geographic regions, with differences in the rates of ectopic pregnancy, live births, induced abortions, miscarriages, and stillbirths. Notably, we observed a decrease in ectopic pregnancies over time. Trials of labor and normal delivery do not escalate maternal or graft-related complications and advocate judicious cesarean delivery. Regarding the interval between transplantation and pregnancy, we found that, although the outcomes in those pregnant 2–3 years post-transplantation were worse, outcomes in those pregnant >3 years post-transplantation were the best when compared with the outcomes in the other groups. Improvements in antenatal care have mitigated risks, such as preeclampsia and maternal mortality, with decreased rates of miscarriage attributed to better immunosuppressive regimens and prenatal care. Despite advancements, the risk of congenital abnormalities remains elevated owing to immunosuppressive medications. Although progress has been made, pregnant kidney transplant recipients still require specialized care. Our findings underscore the importance of ongoing research and technological advancements to further enhance outcomes in this high-risk population.

Supplemental Material

sj-docx-1-whe-10.1177_17455057241277520 – Supplemental material for Pregnancy outcomes in renal transplant recipients: A systematic review and meta-analysis

Supplemental material, sj-docx-1-whe-10.1177_17455057241277520 for Pregnancy outcomes in renal transplant recipients: A systematic review and meta-analysis by Muhammad Saqlain Mustafa, Amber Noorani, Aniqa Abdul Rasool, Fatema Ali Asgar Tashrifwala, Shubha Jayaram, Sandesh Raja, Fatima Jawed, Muhammad Usama Siddiq, Sowmya Govindanahalli Shivappa, Ishaque Hameed and Sriharsha Dadana in Women’s Health

The authors would like to acknowledge the Research Council of Pakistan (RCOP) for their support in all aspects of the study.

Declarations

Author’s Note: Ishaque Hameed is also affiliated to Department of Medicine, Medstar Health, Baltimore, USA.

ORCID iDs: Muhammad Saqlain Mustafa https://orcid.org/0000-0002-3067-3543

Amber Noorani https://orcid.org/0000-0001-6970-9227

Aniqa Abdul Rasool https://orcid.org/0000-0002-8645-9669

Fatema Ali Asgar Tashrifwala https://orcid.org/0000-0002-7537-9719

Supplemental material: Supplemental material for this article is available online.

Ethical considerations: Not applicable, as the study is based exclusively on published literature/medical records.

Consent to participate: Not applicable.

Consent for publication: Not applicable.

Author contribution(s): Muhammad Saqlain Mustafa: Writing – review & editing; Formal analysis; Data curation; Software; Conceptualization.

Amber Noorani: Conceptualization; Writing – original draft; Writing – review & editing; Project administration.

Aniqa Abdul Rasool: Data curation; Validation; Writing – original draft; Conceptualization.

Fatema Ali Asgar Tashrifwala: Writing – original draft; Writing – review & editing; Project administration.

Shubha Jayaram: Methodology; Writing – original draft.

Sandesh Raja: Data curation; Writing – original draft.

Fatima Jawed: Data curation; Writing – original draft.

Muhammad Usama Siddiq: Data curation; Writing – original draft.

Sowmya Govindanahalli Shivappa: Methodology; Writing – original draft.

Ishaque Hameed: Supervision; Writing – review & editing; Conceptualization.

Sriharsha Dadana: Supervision; Writing – review & editing.

Funding: The authors received no financial support for the research, authorship, and/or publication of this article.

The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Data availability statement: All data underlying the results are available as part of the article and no additional source data are required.
==== Refs
References

1 Piccoli GB Cabiddu G Attini R , et al . Outcomes of pregnancies after kidney transplantation: lessons learned from CKD. A comparison of transplanted, non-transplanted chronic kidney disease patients and low-risk pregnancies: a multicenter nationwide analysis. Transplantation 2017; 101 : 2536–2544.28114169
2 Chittka D Hutchinson JA. Pregnancy after renal transplantation. Transplantation 2017; 101 : 675–678.28323773
3 Webster P Lightstone L McKay DB , et al . Pregnancy in chronic kidney disease and kidney transplantation. Kidney Int 2017; 91 : 1047–1056.28209334
4 Shah S Verma P. Overview of pregnancy in renal transplant patients. Int J Nephrol 2016; 2016 : 4539342.28042483
5 You JY Kim MK Choi SJ , et al . Predictive factors for adverse pregnancy outcomes after renal transplantation. Clin Transplant 2014; 28 : 699–706.24654804
6 Bramham K Nelson-Piercy C Gao H , et al . Pregnancy in renal transplant recipients: a UK national cohort study. Clin J Am Soc Nephrol 2013; 8 : 290–298.23085724
7 Page MJ McKenzie JE Bossuyt PM , et al . The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Int J Surg 2021; 88 : 105906.33789826
8 Brooke BS Schwartz TA Pawlik TM. MOOSE reporting guidelines for meta-analyses of observational studies. JAMA Surg 2021; 156 : 787–788.33825847
9 Gosselink ME van Buren MC Kooiman J , et al . A nationwide Dutch cohort study shows relatively good pregnancy outcomes after kidney transplantation and finds risk factors for adverse outcomes. Kidney Int 2022; 102 : 866–875.35777440
10 Devresse A Jassogne C Hubinont C , et al . Maternal risks, and pregnancy outcomes after kidney transplantation: a single center experience. Am J Transplant 2017; 17 : 253.
11 Schwarz A Schmitt R Einecke G , et al . Graft function and pregnancy outcomes after kidney transplantation. BMC Nephrol 2022; 23 : 27.35022021
12 Dines VA Garovic VD Parashuram S , et al . Pregnancy, contraception, and menopause in advanced chronic kidney disease and kidney transplant. Women’s Health Rep (New Rochelle) 2021; 2 : 488–496.34841395
13 Puthenveettil N Mohan A Rahman S , et al . Pregnancy outcomes in renal transplant recipients. Indian J Anaesth 2021; 65 : 695–699.34764505
14 Mira FS Oliveira J Sousa F , et al . Kidney graft function before pregnancy as a predictor of graft, maternal and fetal outcomes in pregnant renal transplant recipients. J Perinat Med 2022; 50 : 185–191.34727592
15 Turgut E İnan G Günaydın DB , et al . Antenatal follow-up, anesthesia management and perinatal outcomes in pregnancy with renal transplant. Turk J Obstet Gynecol 2021; 18 : 109.34083610
16 Akcay OF Yeter HH Karcaaltincaba D , et al . Obstetric and long-term graft outcomes in pregnant kidney transplant recipients: a single-center experience. Clin Transplant 2021; 35 : e14349.
17 Kovač D Kovač L Mertelj T , et al . Pregnancy after kidney transplantation. Transplant Proc 2021; 53 : 1080–1084.33358422
18 Dębska-Ślizień A Gałgowska J Bułło-Piontecka B , et al . Pregnancy after kidney transplantation with maternal and pediatric outcomes: a single-center experience. Transplant Proc 2020; 52 : 2430–2435.32444125
19 Madazlı R Kaymak D Alpay V , et al . Evaluation of obstetric outcomes and prognostic significance of graft function in kidney transplant recipient pregnancies. Hypertens Pregnancy 2020; 39 : 89–94.32069132
20 Ying J Li L Zhai Y , et al . Pregnancy outcomes after renal transplantation: a retrospective case series. Women’s Health Rep (New Rochelle) 2020; 1 : 55–59.33786473
21 Golocan-Alquiza IF Cabanayan-Casasola CB Faustino KM , et al . Patient and graft outcomes among Filipino post-kidney transplant pregnancies. Transplant Proc 2019; 51 : 2718–2723.31477424
22 Hortu I Arı SA Akdemir A , et al . Perinatal outcomes of renal transplant pregnancies: a 22-year experience at a single tertiary referral center. J Matern Fetal Neonatal Med 2020; 33 : 3028–2034.
23 Mariano S Guida JP Sousa MV , et al . Pregnancy among women with kidney transplantation: a 20-years single-center registry. Rev Bras Ginecol Obstet 2019; 41 : 419–424.31250419
24 Özban M Özban AS Birsen O , et al . Pregnancy after renal transplantation. Bratisl Lek Listy 2019; 120 : 368–371.31113200
25 Tebet JL Kirsztajn GM Facca TA , et al . Pregnancy in renal transplant patients: renal function markers and maternal–fetal outcomes. Pregnancy Hypertens 2019; 15 : 108–113.30825905
26 Hassan SM Fahmy R Omran EF , et al . Outcome of pregnancy after renal transplantation. Int J Womens Health 2018; 10 : 65-68.29416379
27 Amine BHH Haythem S Kais H , et al . Pregnancy after renal transplantation: a retrospective study at the military hospital of Tunis from 1992 to 2011. Pan Afr Med J 2017; 28 : 137.29541287
28 Mohammadi FA Borg M Gulyani A , et al . Pregnancy outcomes and impact of pregnancy on graft function in women after kidney transplantation. Clin Transplant 2017; 31 : e13089.
29 Itabashi Y Ohashi Y Muramatsu M , et al . Association between the fertile period and live birth post-kidney transplantation: a retrospective single-center cohort study. Transplant Proc 2017; 49 : 1068–1072.28583529
30 Kihara Y Konno O Yokoyama T , et al . An examination of pregnancy cases after kidney transplantation: single-center experience. Transplant Proc 2018; 50 : 2531–2534.30316392
31 Songin T Pietrzak B Brawura-Biskupski-Samaha R , et al . Pregnancy after kidney and liver transplantation: its outcome and effect on the graft, mother, and neonate. Ann Transplant 2014; 19 : 660–666.25519167
32 Yuksel Y Tekin S Yuksel D , et al . Pregnancy and delivery in the sequel of kidney transplantation: a single-center study of 8 years’ experience. Transplant Proc 2017; 49 : 546–550.28340831
33 Ajaimy M Lubetzky M Jones T , et al . Pregnancy in sensitized kidney transplant recipients: a single-center experience. Clin Transplant 2016; 30 : 791–795.27101447
34 Candido C Cristelli MP Fernandes AR , et al . Pregnancy after kidney transplantation: high rates of maternal complications. J Bras Nefrol 2016; 38 : 421–426.28001172
35 Cristelli M Candido CD Fernandes AR , et al . 109 Pregnancy among kidney transplanted women: feasibility of pregnancy and effects on the mother and renal graft. Pregnancy Hypertens 2016; 6 : 232.
36 El Houssni S Sabri S Benamar L , et al . Pregnancy after renal transplantation: effects on mother, child, and renal graft function. Saudi J Kidney Dis Transpl 2016; 27 : 227–232.26997374
37 Lima A Cristelli M Teixeira C , et al . Pregnancy in the renal transplant recipient: pregnancy viability and effects on graft function. Am J Transplant 2016; 16 : 783–784.26663659
38 Majak GB Sandven I Lorentzen B , et al . Pregnancy outcomes following maternal kidney transplantation: a national cohort study. Acta Obstet Gynecol Scand 2016; 95 : 1153–1161.27288648
39 Mishra VV Nanda S Mistry K , et al . Pregnancy outcome in renal transplant recipients: Indian scenario. Indian J Transplant 2016; 10 : 57–60.
40 Orihuela S Nin M San Roman S , et al . Successful pregnancies in kidney transplant recipients: experience of the National Kidney Transplant Program from Uruguay. Transplant Proc 2016; 48 : 643–645.27110021
41 Piccoli GB Cabiddu G Attini R , et al . Pregnancy outcomes after kidney graft in Italy: are the changes over time the result of different therapies or of different policies? A nationwide survey (1978–2013). Nephrol Dial Transplant 2016; 31 : 1957–1965.27604074
42 Saliem S Patenaude V Abenhaim HA. Pregnancy outcomes among renal transplant recipients and patients with end-stage renal disease on dialysis. J Perinat Med 2016; 44 : 321–327.25719292
43 Santos S Malheiro J Campos A , et al . Pregnancy in renal transplant recipients: obstetric outcomes and risk of allosensitization. Medicine 2016; 95.27334457
44 Sarween N Hughes S Evison F , et al . Pregnancy outcomes in renal transplant recipients in England over 15 years. Nephrol Dial Transplant 2016; 31 : i6.
45 Stoumpos S McNeill SH Gorrie M , et al . Obstetric and long-term kidney outcomes in renal transplant recipients: a 40-yr single-center study. Clin Transplant 2016; 30 : 673–681.26992458
46 Yoshikawa Y Uchida J Akazawa C , et al . Analyses of relationship between obstetric complications and preterm delivery in Japanese recipients received kidney transplant. Transplantation 2016; 100 : S884–S885.
47 Akturk S Celebi ZK Erdogmus S , et al . Pregnancy after kidney transplantation: outcomes, tacrolimus doses, and trough levels. Transplant Proc 2015; 47 : 1442–1444.26093738
48 Arab K Oddy L Patenaude V , et al . Obstetrical and neonatal outcomes in renal transplant recipients. J Matern Fetal Neonatal Med 2015; 28 : 162–167.24678650
49 ErmanAkar M Ozekinci M Sanhal C , et al . A retrospective analysis of pregnancy outcomes after kidney transplantation in a single center. Gynecol Obstet Invest 2015; 79 : 13–18.25277265
50 Yeon HK Shim JY Won HS , et al . Risk factors for developing the preeclamptic disorder in the pregnancy after kidney transplantation. J Perinat Med 2015; 43 : 1293.
51 Debska-Slizien A Galgowska J Chamienia A , et al . Pregnancy after kidney transplantation: a single-center experience and review of the literature. Transplant Proc 2014; 46 : 2668–2672.25380891
52 Farr A Bader Y Husslein PW , et al . Ultra-high-risk pregnancies in women after renal transplantation. Eur J Obstet Gynecol Reprod Biol 2014; 180 :72–76.25048151
53 Hebral AL Cointault O Connan L , et al . Pregnancy after kidney transplantation: outcome and anti-human leucocyte antigen alloimmunization risk. Nephrol Dial Transplant 2014; 29 : 1786–1793.24914091
54 You JY Kim MK Choi SJ , et al . Predictive factors for adverse pregnancy outcomes after renal transplantation. Clin Transplant 2014; 28 : 699–706.24654804
55 Blume C Sensoy A Gross MM , et al . A comparison of the outcome of pregnancies after liver and kidney transplantation. Transplantation 2013; 95 : 222–227.23222883
56 Guella A Mohamed E. Pregnancy in Saudi kidney transplant recipients: a local experience. Transplant Int 2013; 26 : 287.
57 Rachdi M Amine BH Mohamed B , et al . Pregnancy after renal transplantation and neonatal outcome. J Perinat Med 2013; 41.
58 Ribeiro R Grecco R Ribeiro T , et al . Analysis of obstetrical and neonatal outcomes in pregnant women post renal transplantation. J Perinat Med 2013; 41.
59 Rocha A Cardoso A Malheiro J , et al . Pregnancy after kidney transplantation: graft, mother, and newborn complications. Transplant Proc 2013; 45 : 1088–1091.23622633
60 Wyld ML Clayton PA Jesudason S , et al . Pregnancy outcomes for kidney transplant recipients. Am J Transplant 2013; 13 : 3173–3182 24266970
61 Kennedy C Hussein W Spencer S , et al . Reproductive health in Irish female renal transplant recipients. Ir J Med Sci 2012; 181 : 59–63.22033814
62 Neyatani N Yamaguchi N Takagi H , et al . Clinical study on fertility in women received renal transplantation. Int J Gynecol Obstet 2012; 119 : S435–S436.
63 Van Buren MC Van De Wetering J Roodnat JI , et al . Pregnancy after kidney transplantation: “Will mothers see their children grow up?” Transplantation 2012; 94 : 141.
64 Celik G Toz H Ertilav M , et al . Biochemical parameters, renal function, and outcome of pregnancy in kidney transplant recipient. Transplant Proc 2011; 43 : 2579–2583.21911126
65 Gerlei Z Wettstein D Rigo J , et al . Childbirth after organ transplantation in Hungary. Transplant Proc 2011; 43 : 1223–1224.21620095
66 Lopez V Martinez D Vinolo C , et al . Pregnancy in kidney transplant recipients: effects on mother and newborn. Transplant Proc 2011; 43 : 2177–2178.21839226
67 Xu LG Han S Liu Y , et al . Timing, conditions, and complications of post-operative conception and pregnancy in female renal transplant recipients. Cell Biochem Biophys 2011; 61 : 421–426.21573991
68 Gorgulu N Yelken B Caliskan Y , et al . Does pregnancy increase graft loss in female renal allograft recipients? Clin Exp Nephrol 2010; 14 : 244–247.20091332
69 Areia A Galvao A Pais MS , et al . Outcome of pregnancy in renal allograft recipients. Arch Gynecol Obstet 2009; 279 : 273–277.18568355
70 Gill JS Zalunardo N Rose C , et al . The pregnancy rate and live birth rate in kidney transplant recipients. Am J Transplant 2009; 9 : 1541–1549.19459800
71 Levidiotis V Chang S McDonald S. Pregnancy and maternal outcomes among kidney transplant recipients. J Am Soc Nephrol 2009; 20 : 2433–2440.19797167
72 Rizvi SAH Kumari K Naqvi R , et al . An update on pregnancy outcome in renal transplant recipients. Am J Transplant 2009; 9 : 518–519.
73 Sharma U Minocha S. O617 Pregnancy after renal transplant – Oman perspective. Int J Gynecol Obstet 2009; 107 : S269.
74 Al Duraihimh H Ghamdi G Moussa D , et al . Outcome of 234 pregnancies in 140 renal transplant recipients from five middle eastern countries. Transplantation 2008; 85 : 840–843.18360265
75 Alfi AY Al-essawy MA Al-lakany M , et al . Successful pregnancies post renal transplantation. Saudi J Kidney Dis Transpl 2008; 19 : 746–750.18711289
76 Cruz Lemini MC Ibargüengoitia Ochoa F Villanueva González MA. Perinatal outcome following renal transplantation. Int J Gynaecol Obstet 2007; 96 : 76–79 17239381
77 Oliveira LG Sass N Sato JL , et al . Pregnancy after renal transplantation – a five-yr single-center experience. Clin Transplant 2007; 21 : 301–304.17488376
78 Sibanda N Briggs JD Davison JM , et al . Pregnancy after organ transplantation: a report from the UK transplant pregnancy registry. Transplantation 2007; 83 : 1301–1307.17519778
79 Yassaee F Moshiri F. Pregnancy outcome in kidney transplant patients. Urol J 2007; 4 : 14–17.17514605
80 Kurata A Matsuda Y Tanabe K , et al . Risk factors of preterm delivery at less than 35 weeks in patients with renal transplant. Eur J Obstet Gynecol Reprod Biol 2006; 128 : 64–68.16377066
81 Rahamimov R Ben-Haroush A Wittenberg C , et al . Pregnancy in renal transplant recipients: long-term effect on patient and graft survival. A single-center experience. Transplantation 2006; 81 : 660–664.16534465
82 Galdo T Gonzalez F Espinoza M , et al . Impact of pregnancy on the function of transplanted kidneys. Transplant Proc 2005; 37 : 1577–1579.15866678
83 Garcia-Donaire JA Acevedo M Gutierrez MJ , et al . Tacrolimus as basic immunosuppression in pregnancy after renal transplantation. A single-center experience. Transplant Proc 2005; 37 : 3754–3755.16386528
84 Ghanem ME El-Baghdadi LA Badawy AM , et al . Pregnancy outcome after renal allograft transplantation: 15 years experience. Eur J Obstet Gynecol Reprod Biol 2005; 121 : 178–181.16009483
85 Pour-Reza-Gholi F Nafar M Farrokhi F , et al . Pregnancy in kidney transplant recipients. Transplant Proc 2005; 37 : 3090–3092.16213315
86 Yildirim Y Uslu A. Pregnancy in patients with previous successful renal transplantation. Int J Gynaecol Obstet 2005; 90 : 198–202.16043182
87 Keitel E Bruno RM Duarte M , et al . Pregnancy outcome after renal transplantation. Transplant Proc 2004; 36 : 870–871.15194297
88 Pezeshki M Taherian AA Gharavy M , et al . Menstrual characteristics and pregnancy in women after renal transplantation. Int J Gynaecol Obstet 2004; 85 : 119–25.
89 Hooi LS Rozina G Shaariah MY , et al . Pregnancy in patients with renal transplants in Malaysia. Med J Malaysia 2003; 58 : 27–36.14556324
90 Queipo-Zaragoza JA Vera-Donoso CD Soldevila A , et al . Impact of pregnancy on kidney transplant. Transplant Proc 2003; 35 : 866–867.12644170
91 Thompson BC Kingdon EJ Tuck SM , et al . Pregnancy in renal transplant recipients: the Royal Free Hospital experience. QJM 2003; 96 : 837–844.14566039
92 Sgro MD Barozzino T Mirghani HM , et al . Pregnancy outcome post renal transplantation. Teratology 2002; 65 : 5–9.11835226
93 Tan PK Tan AS Tan HK , et al . Pregnancy after renal transplantation: experience in Singapore General Hospital. Ann Acad Med Singapore 2002; 31 : 285–289.12061287
94 Park Y Cho J Kim Y , et al . 360 Pregnancy outcome in renal transplant recipients: the experience of a single center in Korea. Am J Obstet Gynecol 2001; 185 : S180.
95 Kuvacic I Sprem M Skrablin S , et al . Pregnancy outcome in renal transplant recipients. Int J Gynaecol Obstet 2000; 70 : 313–317.10967164
96 Little MA Abraham KA Kavanagh J , et al . Pregnancy in Irish renal transplant recipients in the cyclosporine era. Ir J Med Sci 2000; 169 : 19–21.10846851
97 Moon JI Park SG Cheon KO , et al . Pregnancy in renal transplant patients. Transplant Proc 2000; 32 : 1869–1870.11119976
98 Ventura A Martins L Dias L , et al . Pregnancy in renal transplant recipients. Transplant Proc 2000; 32 : 2611–2612.11134726
99 Arsan A Guest G Gagnadoux MF , et al . Pregnancy in renal transplantation: a pediatric unit report. Transplant Proc 1997; 29 : 2479.9270818
100 Rahbar K Forghani F. Pregnancy in renal transplant recipients: an Iranian experience with a report of triplet pregnancy. Transplant Proc 1997; 29 : 2775.9365558
101 Rieu P Neyrat N Hiesse C , et al . Thirty-three pregnancies in a population of 1725 renal transplant patients. Transplant Proc 1997; 29 : 2459–2460.9270810
102 al Hassani MK Sharma U Mohsin N , et al . Pregnancy in renal transplantation recipients: outcome and complications in 44 pregnancies. Transplant Proc 1995; 27 : 2585.7482838
103 Sabagh TO El Awad MA , et al . Outcome of pregnancy in renal transplant recipients taking cyclosporin a. J Obstet Gynaecol 1995; 15 : 226–229.
104 Saber LT Duarte G Costa JA , et al . Pregnancy and kidney transplantation: experience in a developing country. Am J Kidney Dis 1995; 25 : 465–470.7872326
105 Wong KM Bailey RR Lynn KL , et al . Pregnancy in renal transplant recipients: the Christchurch experience. N Z Med J 1995; 108 : 190–192.7783987
106 Hadi HA Stafford CR Williamson JR , et al . Pregnancy outcome in renal transplant recipients: experience at the Medical College of Georgia and review of the literature. South Med J 1986; 79 : 959–964.3526573
107 Talaat KM Tyden G Bjorkman U , et al . Thirty successful pregnancies in organ transplant recipients: a single-center experience. Transplant Proc 1994; 26 : 1773.8030128
108 Pahl MV Vaziri ND Kaufman DJ , et al . Childbirth after renal transplantation. Transplant Proc 1993; 25 : 2727–2731.8356728
109 Muirhead N Sabharwal AR Rieder MJ , et al . The outcome of pregnancy following renal transplantation – the experience of a single center. Transplantation 1992; 54 : 429–432.1412722
110 Brown JH Maxwell AP McGeown MG. Outcome of pregnancy following renal transplantation. Ir J Med Sci 1991; 160 : 255–256.1938314
111 Sturgiss SN Davison JM. Perinatal outcome in renal allograft recipients: prognostic significance of hypertension and renal function before and during pregnancy. Obstet Gynecol 1991; 78 : 573–577.1923157
112 O’Connell PJ Caterson RJ Stewart JH , et al . Problems associated with pregnancy in renal allograft recipients. Int J Artif Organs 1989; 12 : 147–152.2663732
113 Ha J Kim SJ Kim ST. Pregnancy following renal transplantation. Transplant Proc 1994; 26 : 2117–2118.8066689
114 Marushak A Weber T Bock J , et al . Pregnancy following kidney transplantation. Acta Obstet Gynecol Scand 1986; 65 : 557–559.3541482
115 O’Donnell D Sevitz H Seggie JL. Pregnancy after renal transplantation. Aust NZ J Med 1985; 15 : 320–325.
116 Waltzer WC Coulam CB Zincke H , et al . Pregnancy in renal transplantation. Transplant Proc 1980; 12 : 221–226.6989058
117 Hamilton BE, Martin JA, Osterman MJK. Births: Provisional data for 2021. Vital Statistics Rapid Release; no 20. Hyattsville, MD: National Center for Health Statistics. May 2022
118 Kortsmit K Nguyen AT Mandel MG , et al . Abortion surveillance – United States, 2020. MMWR Surveill Summ, 2022; 71 : 1–27.
119 Gregory ECW, Valenzuela CP, Hoyert DL. Fetal mortality: United States, 2020. National Vital Statistics Reports; vol 71 no 4. Hyattsville, MD: National Center for Health Statistics. 2022.
120 Shah S Venkatesan RL Gupta A , et al . Pregnancy outcomes in women with kidney transplant: metaanalysis and systematic review. BMC Nephrol 2019; 20 : 24.30674290
121 Osterman MJK. Changes in primary and repeat cesarean delivery: United States, 2016–2021. Vital Statistics Rapid Release; no 21. Hyattsville, MD: National Center for Health Statistics. July 2022.
122 Ananth CV Keyes KM Wapner RJ. Pre-eclampsia rates in the United States, 1980–2010: age-period-cohort analysis. BMJ 2013; 347.
123 Gregory ECW, Ely DM. Trends and characteristics in gestational diabetes: United States, 2016–2020. National Vital Statistics Reports; vol 71 no 3. Hyattsville, MD: National Center for Health Statistics. 2022.
124 World Health Organization. Preterm birth, www.who.int/news-room/fact-sheets/detail/preterm-birth (2023, accessed 9 June 2023).
125 Pathirana J Muñoz FM Abbing-Karahagopian V , et al . Neonatal death: case definition & guidelines for data collection, analysis, and presentation of immunization safety data. Vaccine 2016; 34 : 6027–6037.27449077
126 Centers for Disease Control and Prevention. Products – vital statistics rapid release – infant mortality, www.cdc.gov/nchs/nvss/vsrr/infant-mortality.htm (2023, accessed 9 June 2023).
127 Declercq E Wolterink A Rowe R , et al . The natural pattern of birth timing and gestational age in the U.S. compared to England, and the Netherlands. PLoS One 2023; 18 : e0278856.
128 Donahue SM Kleinman KP Gillman MW , et al . Trends in birth weight and gestational length among singleton term births in the United States: 1990–2005. Obstet Gynecol 2010; 115 : 357–364.20093911
129 Health Resources and Services Administration. OPTN/SRTR 2019 Annual Data Report: Kidney, https://srtr.transplant.hrsa.gov/annual_reports/2019/Kidney.aspx (accessed 9 June 2023).
130 Moritz MJ Constantinescu S Coscia LA , et al . Transplant Pregnancy Registry International 2017 Annual Report. Philadelphia: Gift of Life Institute, 2018.
131 Fontana I Santori G Fazio F , et al . The pregnancy rate and live birth rate after kidney transplantation: a single-center experience. Transplant Proc 2012; 44 : 1910–1911.22974868
132 Deshpande NA James NT Kucirka LM , et al . Pregnancy outcomes in kidney transplant recipients: a systematic review and meta-analysis: pregnancy outcomes in kidney transplant recipients. Am J Transplant 2011; 11 : 2388–2404.21794084
133 McKay DB Josephson MA. Pregnancy after kidney transplantation. Clin J Am Soc Nephrol 2008; 3 : S117–S125.18308999
134 del Mar Colon M Hibbard JU . Obstetric considerations in the management of pregnancy in kidney transplant recipients. Adv Chronic Kidney Dis 2007; 14 : 168–177.17395119
135 Coscia, L. A., Constantinescu, S., Moritz, M. J., Frank, A. M., Ramirez, C. B., Maley, W. R., Doria, C., McGrory, C. H., & Armenti, V. T. (2010). Clinical transplants (Chapter 7).
136 Klein CL Josephson MA. Post-transplant pregnancy and contraception. Clin J Am Soc Nephrol 2022; 17 : 114–120.33731339
137 Coscia LA Armenti DP King RW , et al . Update on the teratogenicity of maternal mycophenolate mofetil. J Pediatr Genet 2015; 4 : 42–55 27617117
138 Hewawasam E Davies CE Li Z , et al . Determinants of perinatal outcomes in dialyzed and transplanted women in Australia. Kidney Int Rep 2022; 7 : 1318–1331.35685315
139 Sayin B Akdur A Dogan B , et al . P8. 112: Pregnancy outcomes in kidney transplant recipients and their newborns. Transplantation 2022; 106 : S610.
140 Haas M Mayer G. Cyclosporin A-associated hypertension – pathomechanisms and clinical consequences. Nephrol Dial Transplant 1997; 12 : 395–398.9075115
141 Armenti VT Daller JA Constantinescu S , et al . Report from the National Transplantation Pregnancy Registry: outcomes of pregnancy after transplantation. Clin Transpl 2006 : 57–70.
142 Cosio FG Pesavento TE Kim S , et al . Patient survival after renal transplantation: IV. Impact of post-transplant diabetes. Kidney Int 2002; 62 : 1440–1446.12234317
143 Gordon EJ Ladner DP Caicedo JC , et al . Disparities in kidney transplant outcomes: a review. Semin Nephrol 2010; 30 : 81–89.20116652
144 Wielgos M Szpotanska-Sikorska M Mazanowska N , et al . Pregnancy risk in female kidney and liver recipients: a retrospective comparative study. J Matern Fetal Neonatal Med 2012; 25 : 1090–1095.21919553
145 Madej A Mazanowska N Szpotańska-Sikorska M , et al . Delivery method in patients after liver or kidney transplantation. Transplant Proc 2018; 50 : 2150–2153.30177128
146 Yin O Kallapur A Coscia L , et al . Mode of obstetric delivery in kidney and liver transplant recipients and associated maternal, neonatal, and graft morbidity during 5 decades of clinical practice. JAMA Netw Open 2021; 4 : e2127378.
